首页/数据集/Glaucoma risks by exposure status of antidepressant use.

Glaucoma risks by exposure status of antidepressant use.

NIAID Data Ecosystem2026-03-10 收录

药物安全性评估

青光眼风险因素

数据链接：

https://figshare.com/articles/dataset/Glaucoma_risks_by_exposure_status_of_antidepressant_use_/4722685 数据链接链接失效反馈

官方服务：

资源简介：

Glaucoma risks by exposure status of antidepressant use.

应用场景：

创建时间：

2017-03-03

青光眼风险因素

眼科疾病进展

MD = mean defect, OR = odds ratio, CI = confidence interval, VCDR = vertical cup-to-disk ratio. †Candidate risk factors included: age, gender, right/left eye, central corneal thickness, BCVA (logMAR),

NIAID Data Ecosystem60

Adverse events by treatment arm, intention-to-treat population (N = 1761).

临床试验不良事件

药物安全性评估

Adverse events by treatment arm, intention-to-treat population (N = 1761).

NIAID Data Ecosystem40

Pharmacovigilance of patients with multiple myeloma being treated with bortezomib and/or thalidomide

多发性骨髓瘤药物不良反应

药物安全性评估

In order to evaluate the main adverse effects of drug protocols using bortezomib and/or thalidomide for the treatment of multiple myeloma, we conducted a prospective study. Data were collected through

NIAID Data Ecosystem20

Megadoses and mortality (multivariate analysis adjusted according to patient age, comorbidities and other treatments).

药物安全性评估

临床流行病学

Megadoses and mortality (multivariate analysis adjusted according to patient age, comorbidities and other treatments).

NIAID Data Ecosystem50

Results of univariate logistic regressions in cases treated with GLD dead due to confirmed fatal hyperglycaemia versus matched controls.

药物安全性评估

高血糖症风险分析

Categorical variables given as number and proportions (%).

NIAID Data Ecosystem40